We brings precise microencapsulation at industrial scale: Microcaps developed a novel technology that enables the scalable production of precise microcapsules and microparticles based on microfluidics.
Microcaps has raised €9.6M across 2 funding rounds from 6 investors, most recently a round in Jul 2026. Based in Zurich, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-07-07 | Other | — | Givaudan | View deal → |
| 2024-06-07 | Series A | €9.6M | ETH Foundation,Existing Shareholders,Helvetica Capital,Private Investors,Zürcher Kantonalbank | View deal → |
